Cargando…
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy
Autores principales: | Yoshihara, Kyoko, Matsuda, Ikuo, Utsunomiya, Nobuto, Samori, Mami, Hirata, Saki, Okada, Masaya, Hirota, Seiichi, Higasa, Satoshi, Yoshihara, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357245/ https://www.ncbi.nlm.nih.gov/pubmed/34396050 http://dx.doi.org/10.1097/HS9.0000000000000628 |
Ejemplares similares
-
T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone
por: Yoshihara, Kyoko, et al.
Publicado: (2021) -
Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapy
por: Yoshihara, Kyoko, et al.
Publicado: (2022) -
Characteristics of Taiwanese patients of PNH in the international PNH registry
por: Chou, Wen-Chien, et al.
Publicado: (2016) -
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Kitajima, Kazuhiro, et al.
Publicado: (2019) -
A complementary new drug for PNH
por: Brodsky, Robert A.
Publicado: (2020)